Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs Indian Medical PG Practice Questions and MCQs

Question 221: Which nerve supplies the dilator pupillae muscle?

A. Postganglionic parasympathetic fibers from the Edinger-Westphal nucleus
B. Postganglionic sympathetic fibers from the cervical sympathetic chain (Correct Answer)
C. The third cranial nerve (oculomotor nerve)
D. Sympathetic fibers of the fronto-orbital branch of the trigeminal nerve

Explanation: ### Explanation The **dilator pupillae** (radial muscle of the iris) is responsible for **mydriasis** (pupillary dilation). This muscle is under the control of the **sympathetic nervous system**. **Why Option B is Correct:** The sympathetic pathway for the eye follows a three-neuron arc: 1. **First-order neurons** originate in the hypothalamus and descend to the **ciliospinal center of Budge** (C8–T2). 2. **Second-order (preganglionic) neurons** exit the spinal cord and ascend to the **superior cervical ganglion**. 3. **Third-order (postganglionic) neurons** originate in the superior cervical ganglion, travel along the internal carotid artery, and reach the dilator pupillae via the long ciliary nerves. **Analysis of Incorrect Options:** * **Option A & C:** The **Edinger-Westphal nucleus** is the parasympathetic nucleus of the **third cranial nerve (Oculomotor)**. It supplies the **sphincter pupillae** (causing miosis) and the ciliary muscle (causing accommodation), not the dilator pupillae. * **Option D:** While sympathetic fibers do travel "hitchhiking" with branches of the trigeminal nerve (specifically the ophthalmic division/V1) to reach the eye, they originate from the **cervical sympathetic chain**, not a "fronto-orbital branch." **Clinical Pearls for NEET-PG:** * **Horner’s Syndrome:** Caused by a lesion anywhere along the sympathetic pathway described above. Clinical triad: **Ptosis** (superior tarsal muscle), **Miosis** (paralysis of dilator pupillae), and **Anhidrosis**. * **Pharmacology Link:** Mydriasis without cycloplegia (paralysis of accommodation) is produced by **alpha-1 agonists** (e.g., Phenylephrine) because they act directly on the dilator pupillae without affecting the ciliary muscle. * **Mnemonic:** **S**ympathetic = **S**uperior Cervical Ganglion = **S**ize increases (Mydriasis).

Question 222: Which drug is primarily used in the management of Alzheimer's disease?

A. Tacrine
B. Rivastigmine (Correct Answer)
C. Pyridostigmine
D. Neostigmine

Explanation: **Explanation:** **Rivastigmine** is the correct answer because it is a centrally acting, reversible acetylcholinesterase inhibitor (AChEI) that effectively crosses the blood-brain barrier. In Alzheimer’s disease, there is a progressive loss of cholinergic neurons in the nucleus basalis of Meynert. By inhibiting the breakdown of acetylcholine in the synaptic cleft, Rivastigmine enhances cholinergic neurotransmission, thereby improving cognitive function and slowing the progression of symptoms. **Analysis of Options:** * **Tacrine (A):** Although it was the first AChEI approved for Alzheimer’s, it is no longer used clinically due to significant **hepatotoxicity** and the requirement for frequent dosing. * **Pyridostigmine (C):** This is a quaternary ammonium compound that does not cross the blood-brain barrier. It is primarily used in the management of **Myasthenia Gravis** due to its longer duration of action compared to Neostigmine. * **Neostigmine (D):** Like Pyridostigmine, it is a polar quaternary amine with poor CNS penetration. It is used for reversing neuromuscular blockade (post-surgery), Myasthenia Gravis, and paralytic ileus. **Clinical Pearls for NEET-PG:** * **Rivastigmine Unique Feature:** It is the only AChEI available as a **transdermal patch**, which reduces gastrointestinal side effects (nausea/vomiting) and improves patient compliance. * **Other Alzheimer’s Drugs:** Donepezil and Galantamine are other AChEIs used. **Memantine** (an NMDA receptor antagonist) is used for moderate-to-severe cases. * **Side Effects:** Common side effects of these drugs are cholinergic in nature: diarrhea, urination, miosis, bradycardia, and salivation (DUMBELS).

Question 223: Alpha bungarotoxin acts at which site?

A. Acetylcholine synthesis
B. Acetylcholine receptors (Correct Answer)
C. Acetylcholine secretion
D. Acetylcholine release

Explanation: **Explanation:** **Alpha-bungarotoxin** is a potent neurotoxin derived from the venom of the many-banded krait (*Bungarus multicinctus*). Its primary mechanism of action is the **irreversible competitive blockade of nicotinic acetylcholine receptors (nAChR)** at the motor endplate of the neuromuscular junction. By binding with high affinity to the alpha subunits of these receptors, it prevents acetylcholine (ACh) from binding, leading to flaccid paralysis and respiratory failure. **Analysis of Options:** * **Option B (Correct):** Alpha-bungarotoxin acts directly on the **postsynaptic receptors**. It is widely used in research to quantify and localize nicotinic receptors due to its nearly irreversible binding. * **Option A (Incorrect):** ACh synthesis is primarily inhibited by drugs like **Hemicholinium** (which blocks choline uptake). * **Option C & D (Incorrect):** Inhibition of ACh release/secretion from the presynaptic terminal is the mechanism of **Botulinum toxin** (which cleaves SNARE proteins) and **Beta-bungarotoxin** (which has phospholipase A2 activity). **High-Yield Clinical Pearls for NEET-PG:** * **Alpha-bungarotoxin:** Postsynaptic blocker (similar to d-tubocurarine but irreversible). * **Beta-bungarotoxin:** Presynaptic blocker (inhibits ACh release). * **Snake Venom Correlation:** The paralysis caused by krait venom is often poorly reversed by neostigmine because alpha-bungarotoxin binds so tightly to the receptor. * **Diagnostic Use:** Radioactive iodine-labeled alpha-bungarotoxin is used in the diagnosis and study of **Myasthenia Gravis** to measure the number of functional nicotinic receptors.

Question 224: A patient is administered pilocarpine. All of the following can be the features seen in him except?

A. Sweating
B. Salivation
C. Miosis
D. Cycloplegia (Correct Answer)

Explanation: **Explanation:** Pilocarpine is a **direct-acting cholinergic agonist** (parasympathomimetic) that primarily acts on muscarinic receptors ($M_1, M_2, M_3$). To answer this question, one must distinguish between drugs that stimulate the parasympathetic nervous system versus those that block it. **Why Cycloplegia is the Correct Answer:** Cycloplegia refers to the **paralysis of the ciliary muscle**, resulting in the loss of accommodation. This is a characteristic effect of **anticholinergic** drugs (like Atropine) which block $M_3$ receptors. In contrast, Pilocarpine causes **contraction** of the ciliary muscle (spasm of accommodation), which leads to "cyclospasm" and blurring of distant vision, not cycloplegia. **Analysis of Incorrect Options:** * **Sweating (A):** Pilocarpine is a potent diaphoretic. Although sweat glands are part of the sympathetic system anatomically, they are mediated by **cholinergic ($M_3$) receptors**. Thus, pilocarpine significantly increases sweating. * **Salivation (B):** As a parasympathomimetic, pilocarpine stimulates exocrine glands. It is clinically used to treat xerostomia (dry mouth) in Sjogren’s syndrome. * **Miosis (C):** Pilocarpine causes contraction of the **sphincter pupillae** muscle of the iris, leading to pupillary constriction (miosis). This action helps open the trabecular meshwork, making it useful in treating glaucoma. **NEET-PG High-Yield Pearls:** * **Drug of Choice:** Pilocarpine is the DOC for **Acute Angle Closure Glaucoma** (to rapidly induce miosis). * **Ciliary Muscle:** Contraction (Pilocarpine) = Accommodation for near vision; Relaxation (Atropine) = Cycloplegia (loss of accommodation). * **Side Effect:** The most common side effect of ophthalmic pilocarpine is brow ache due to ciliary muscle spasm.

Question 225: Blockade of the vasomotor reversal phenomenon is seen with which of the following drugs?

A. Atenolol (Correct Answer)
B. Noradrenaline
C. Dopamine
D. Epinephrine

Explanation: ### Explanation **Concept: Dale’s Vasomotor Reversal** Dale’s vasomotor reversal occurs when **Adrenaline (Epinephrine)** is administered after an **alpha-blocker**. Normally, Adrenaline causes a rise in blood pressure (BP) due to its potent $\alpha_1$ (vasoconstriction) and $\beta_1$ (cardiac stimulation) effects. However, if $\alpha$-receptors are blocked, only the $\beta_2$ (vasodilation) effect remains, causing the BP to fall instead of rise [1]. **Why Atenolol is the Correct Answer:** To "block" or prevent this reversal phenomenon, one must block the receptor responsible for the fall in BP—the **$\beta$-receptor**. * **Atenolol** is a cardioselective $\beta_1$ blocker. While it primarily acts on the heart, at higher doses or in clinical scenarios involving $\beta$-blockade, it prevents the $\beta$-mediated vasodilation/hypotension that characterizes the reversal phenomenon [1]. * *Note:* In many textbooks, non-selective $\beta$-blockers like **Propranolol** are the classic examples used to "block the reversal," but among the given options, Atenolol is the only $\beta$-blocker. **Analysis of Incorrect Options:** * **B. Noradrenaline:** It lacks significant $\beta_2$ activity. Therefore, it does not show the vasomotor reversal phenomenon in the first place (it causes a rise in BP even after $\alpha$-blockade). * **C. Dopamine:** It acts on $D_1$, $\beta_1$, and $\alpha_1$ receptors. While it can cause vasodilation via $D_1$, it is not the classic drug used to demonstrate or block Dale's reversal. * **D. Epinephrine:** This is the drug used to *demonstrate* the phenomenon, not block it. **High-Yield Clinical Pearls for NEET-PG:** * **Dale’s Reversal:** Adrenaline + Alpha-blocker (e.g., Phentolamine) = Fall in BP [1]. * **Blocking the Reversal:** Adrenaline + Alpha-blocker + Beta-blocker = No fall in BP (BP may rise slightly or stay neutral) [1]. * **Vasomotor Phenomenon of Sir Henry Dale** is a classic experiment on dogs using ergot alkaloids (the first known $\alpha$-blockers) [1].

Question 226: Which muscarinic receptor inhibits adenyl cyclase activity?

A. M1
B. M2 (Correct Answer)
C. M3
D. M4

Explanation: **Explanation:** Muscarinic receptors are G-protein coupled receptors (GPCRs) categorized based on their signaling pathways. To answer this question, remember the high-yield mnemonic: **"QIQ"** for receptors M1, M2, and M3. * **M1:** Gq-coupled (Stimulatory) * **M2:** Gi-coupled (Inhibitory) * **M3:** Gq-coupled (Stimulatory) **Why M2 is correct:** M2 receptors are coupled with **Gi (inhibitory) proteins**. Activation of the Gi protein leads to the **inhibition of Adenyl Cyclase**, which subsequently decreases the levels of intracellular cyclic AMP (cAMP). In the heart (SA and AV nodes), this leads to the opening of K+ channels and hyperpolarization, resulting in decreased heart rate (negative chronotropy) and conduction velocity. **Why other options are incorrect:** * **M1 & M3:** These are coupled to **Gq proteins**. Their activation stimulates **Phospholipase C (PLC)**, which cleaves PIP2 into IP3 and DAG, leading to increased intracellular calcium. They do not inhibit adenyl cyclase. * **M4:** While M4 is also Gi-coupled and inhibits adenyl cyclase (similar to M2), it is primarily located in the CNS (striatum). In the context of standard pharmacology exams like NEET-PG, when a single best answer is required regarding the primary "inhibitory" muscarinic receptor, **M2** is the classic clinical representative due to its profound effects on the heart. **High-Yield Clinical Pearls for NEET-PG:** * **M1 Location:** "Nerves" (CNS, Gastric parietal cells). * **M2 Location:** "Heart" (Atria, SA/AV nodes). * **M3 Location:** "Everything else" (Smooth muscle contraction, Glandular secretion, Miosis/Ciliary muscle contraction). * **Drug Link:** Atropine is a non-selective muscarinic antagonist; it blocks M2 receptors in the heart to treat symptomatic bradycardia.

Question 227: A 45-year-old male presented with features of hyperthermia, bronchodilatation, constipation, and palpitations. He is likely suffering from poisoning of which of the following?

A. Organophosphorus compound
B. Oximes
C. Atropine (Correct Answer)
D. Mushroom

Explanation: ### Explanation The clinical presentation described—**hyperthermia, bronchodilatation, constipation, and palpitations**—is a classic manifestation of **Anticholinergic Syndrome**, caused by the blockade of muscarinic receptors. **1. Why Atropine is Correct:** Atropine is a competitive antagonist of muscarinic acetylcholine receptors. Its effects can be remembered by the physiological blockade of the parasympathetic nervous system: * **Hyperthermia:** Blockade of M3 receptors on sweat glands leads to "anhydrosis" (suppression of sweating), causing a rise in body temperature (**"Hot as a hare"**). * **Bronchodilatation:** Blockade of M3 receptors in the bronchial smooth muscle. * **Constipation:** Decreased gastrointestinal motility due to M3 blockade. * **Palpitations:** Blockade of M2 receptors in the SA node leads to tachycardia. **2. Why Other Options are Incorrect:** * **Organophosphorus (OP) Compounds:** These inhibit acetylcholinesterase, leading to cholinergic overstimulation (DUMBELS: Diarrhea, Urination, Miosis, Bradycardia, Emesis, Lacrimation, Salivation). This is the exact opposite of the symptoms described. * **Oximes (e.g., Pralidoxime):** These are cholinesterase reactivators used to treat OP poisoning; they do not cause this toxidrome. * **Mushroom:** Most poisonous mushrooms (like *Amanita muscaria*) contain muscarine, which causes **cholinergic** symptoms (miosis, bradycardia, sweating). *Note: Only specific rare species containing ibotenic acid mimic atropine.* **3. NEET-PG High-Yield Pearls:** * **Mnemonic for Atropine Poisoning:** "Red as a beet (flushing), Dry as a bone (no sweat/saliva), Blind as a bat (mydriasis/cycloplegia), Hot as a hare (hyperthermia), and Mad as a hatter (delirium)." * **Drug of Choice for Atropine Poisoning:** **Physostigmine** (a tertiary amine carbamate that crosses the blood-brain barrier). * **Contraindication:** Atropine is strictly contraindicated in patients with **Glaucoma** (due to mydriasis) and **Benign Prostatic Hyperplasia** (due to urinary retention).

Question 228: Tolterodine, used in overactive bladder, acts by blocking which of the following receptors?

A. M1
B. M2
C. M3 (Correct Answer)
D. M4

Explanation: **Explanation:** **Mechanism of Action:** Tolterodine is a competitive **muscarinic receptor antagonist** specifically used for the treatment of overactive bladder (OAB). The detrusor muscle of the urinary bladder is primarily under the control of the parasympathetic nervous system. While both M2 and M3 receptors are present in the bladder, the **M3 receptor** is the subtype responsible for **bladder contraction**. By blocking M3 receptors, Tolterodine reduces detrusor pressure and decreases the frequency of involuntary bladder contractions, thereby alleviating symptoms of urgency and incontinence. **Analysis of Options:** * **M1 (Option A):** These are primarily located in the CNS and gastric glands. Blocking M1 is associated with cognitive impairment (e.g., Pirenzepine is an M1 blocker used for peptic ulcers). * **M2 (Option B):** These are predominantly found in the heart (SA and AV nodes). Blocking M2 leads to tachycardia. While M2 receptors exist in the bladder, they do not directly mediate contraction as significantly as M3. * **M4 (Option D):** These are mainly located in the CNS and are involved in modulating dopamine release; they have no clinical role in bladder dynamics. **High-Yield Clinical Pearls for NEET-PG:** * **Selectivity:** Unlike older drugs like Oxybutynin, Tolterodine is more "uroselective" in its functional effect, leading to a lower incidence of **xerostomia (dry mouth)**. * **Other M3 Blockers for OAB:** Darifenacin and Solifenacin are even more highly selective for the M3 subtype. * **Contraindication:** Like all anticholinergics, Tolterodine is contraindicated in patients with **Narrow-Angle Glaucoma** and **Prostatic Hyperplasia** (due to risk of acute urinary retention). * **Mirabegron:** A newer alternative for OAB that acts as a **β3-agonist**, avoiding anticholinergic side effects.

Question 229: Atropine is used in all EXCEPT:

A. Glaucoma (Correct Answer)
B. Mydriatic
C. Cyclopegic
D. Preanaesthetic medication

Explanation: **Explanation:** **1. Why Glaucoma is the Correct Answer (Contraindication):** Atropine is a potent **muscarinic antagonist**. In the eye, it causes **mydriasis** (dilation of the pupil) by blocking the M3 receptors on the sphincter pupillae muscle. This causes the iris tissue to fold back into the iridocorneal angle, potentially obstructing the trabecular meshwork. In patients with narrow-angle glaucoma, this can trigger an acute attack of congestive glaucoma by preventing the drainage of aqueous humor, leading to a dangerous rise in intraocular pressure (IOP). Therefore, Atropine is strictly **contraindicated** in glaucoma. **2. Analysis of Other Options:** * **Mydriatic:** Atropine is used to dilate the pupil (mydriasis) to facilitate fundus examination, though shorter-acting agents like Tropicamide are now preferred. * **Cycloplegic:** By blocking M3 receptors on the ciliary muscle, Atropine causes paralysis of accommodation (cycloplegia). This is essential for accurate refraction testing, especially in children with high accommodative tone. * **Preanaesthetic Medication:** Atropine is used before surgery to decrease salivary and bronchial secretions (preventing aspiration) and to prevent vagally-mediated bradycardia during intubation or surgery. **3. High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Atropine is the DOC for **Symptomatic Bradycardia** and **Organophosphate Poisoning** (to reverse muscarinic effects). * **Antidote:** The specific antidote for Atropine poisoning is **Physostigmine** (a tertiary amine that crosses the blood-brain barrier). * **Duration:** Atropine is the longest-acting mydriatic (effects can last 7–10 days). * **Memory Aid:** "Dry as a bone, Red as a beet, Hot as a hare, Blind as a bat, Mad as a hatter" (Symptoms of Atropine toxicity).

Question 230: What is a true statement about pralidoxime?

A. Signs of atropinization occur more slowly when pralidoxime is used compared to the use of atropine alone.
B. It can be used for chlorinated pesticides.
C. It should not be used for nerve gases used in chemical warfare.
D. Therapy with pralidoxime should ideally be monitored by measuring blood cholinesterase concentration. (Correct Answer)

Explanation: Pralidoxime (2-PAM) is a **cholinesterase reactivator** used in the management of organophosphate (OP) poisoning [1, 2]. **Why Option D is Correct:** The primary goal of pralidoxime therapy is to restore the activity of the enzyme acetylcholinesterase (AChE) [1, 2]. Therefore, the most objective way to monitor the efficacy of treatment and decide on the duration of therapy is by measuring **erythrocyte (RBC) cholinesterase levels**. A rise in these levels indicates successful enzyme reactivation [1]. **Analysis of Incorrect Options:** * **Option A:** Pralidoxime works synergistically with atropine. By reactivating the enzyme, it reduces the total amount of acetylcholine at the synapse, which actually **accelerates** the appearance of signs of atropinization (e.g., clearance of secretions, pupillary dilation). * **Option B:** Pralidoxime is specific for **Organophosphates**. It is ineffective against chlorinated pesticides (like DDT) because they do not inhibit cholinesterase; they act primarily on sodium channels. * **Option C:** Pralidoxime (and newer oximes like Obidoxime) are the **standard treatment** for nerve gases (e.g., Sarin, Soman, Tabun), which are potent organophosphates used in chemical warfare. **High-Yield Clinical Pearls for NEET-PG:** 1. **The "Aging" Phenomenon:** Pralidoxime must be administered early (ideally within 24–48 hours). Once the enzyme-toxin bond "ages" (dealkylation), oximes can no longer reactivate the enzyme [1, 2]. 2. **Carbamate Poisoning:** Pralidoxime is generally **not recommended** for carbamate poisoning (like Neostigmine or Sevin) because the carbamylation of AChE is spontaneously reversible and oximes may even worsen the toxicity (especially with Carbaryl). 3. **Blood-Brain Barrier:** Pralidoxime is a quaternary ammonium compound; it does **not** cross the BBB and thus cannot reverse central respiratory depression (Atropine is required for CNS effects).

Practice by Chapter

Cholinergic Agonists

Practice Questions

Cholinergic Antagonists

Practice Questions

Adrenergic Agonists

Practice Questions

Adrenergic Antagonists

Practice Questions

Ganglionic Agents

Practice Questions

Neuromuscular Blocking Agents

Practice Questions

Autonomic Drugs in Ophthalmology

Practice Questions

Autonomic Drugs in Cardiovascular Disease

Practice Questions

Autonomic Drugs in Respiratory Disease

Practice Questions

Autonomic Drugs in Urological Disorders

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free